Peer-Reviewed Journal Details
Mandatory Fields
Falco, EE,Wang, MO,Thompson, JA,Chetta, JM,Yoon, DM,Li, EZ,Kulkami, MM,Shah, S,Pandit, A,Roth, JS,Fisher, JP
2011
June
Pharmaceutical Research
Porous EH and EH-PEG Scaffolds as Gene Delivery Vehicles to Skeletal Muscle
Published
()
Optional Fields
cyclic acetal gene therapy IGF-1 synthetic meshes GROWTH-FACTOR-I BIOMATERIALS REGENERATION EXPRESSION POLYMERS INSULIN CELLS BIOTECHNOLOGY TRANSFECTION HYPERTROPHY
28
1306
1316
Purpose Synthetic biomaterials are widely used in an attempt to control the cellular behavior of regenerative tissues. This can be done by altering the chemical and physical properties of the polymeric scaffold to guide tissue repair. This paper addresses the use of a polymeric scaffold (EH network) made from the cyclic acetal monomer, 5-ethyl-5-(hydroxymethyl)-beta,beta-dimethyl-1,3-dioxane-2-ethanol diacrylate (EHD), as a release device for a therapeutic plasmid encoding for an insulin-like growth factor-1 green fluorescent protein fusion protein (IGF-1 GFP).Methods Scaffolds were designed to have different porous architectures, and the impact of these architectures on plasmid release was determined. We hypothesized that IGF-1 could be delivered more effectively using a porous scaffold to allow for the release of IGF-1.Results We showed that by altering the number of pores exposed to the surface of the network, faster plasmid loading and release were achieved. In addition, the IGF-1 GFP plasmids were found to be effective in producing IGF-1 and GFP within human skeletal muscle myoblast cell cultures.Conclusions This work aims to show the utility of EH biomaterials for plasmid delivery for potentially localized skeletal muscle regeneration.
DOI 10.1007/s11095-010-0358-5
Grant Details
Publication Themes